“In our tests, Zap-CHO increased cell growth an average of 190% across all media and extended cell viability by delaying apoptosis. Most importantly, Zap-CHO increased volumetric productivity an average of 179%.”
Fort Collins, CO (PRWEB) December 16, 2009
Scientists working with CHO cells can now access an informational online video featuring a presentation by Dr. Steve Pettit, InVitria’s Director of Cell Culture Product Development. Zap-CHO is a robust CHO cell supplement that maximizes CHO cell line performance and speeds-up cell line development processes. Zap-CHO is not a hydrolysate; it is an animal free, well defined and consistent recombinant CHO supplement.
Dr. Pettit guides viewers through the online video by describing the work done to test the effectiveness of Zap-CHO on CHO cell growth and productivity. “We tested Zap-CHO in the leading chemically-defined, serum- and protein-free cell culture media available on the market today,” said Dr. Pettit. “In our tests, Zap-CHO increased cell growth an average of 190% across all media and extended cell viability by delaying apoptosis. Most importantly, Zap-CHO increased volumetric productivity an average of 179%.”
In the video, Dr. Pettit points out the distinct advantages Zap-CHO gives scientists who are trying to improve their CHO cell line performance, including:
- Faster cell growth
- Higher peak cell density
- Reduced apoptosis
- Increased viability
- Maximized productivity
- Easy removal by Protein A chromatography during downstream purification
Further, Zap-CHO helps scientists working in clone selection by improving growth and shortening timelines; in seed train expansion by reducing the amount of time from cell bank to bioreactor; in cell adaptation by reducing the timelines for media adaptation; and, in bioproduction by maximizing antibody titre.
To watch the Zap-CHO product video click here.
To purchase Zap-CHO:
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media supplements and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.
# # #